These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25418592)

  • 1. [Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy].
    Pellegrini I; Prodromou N; Coupier I; Huiart L; Moretta J; Noguès C; Julian-Reynier C
    Bull Cancer; 2014 Nov; 101(11):1001-8. PubMed ID: 25418592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
    Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
    J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditions and consequences of a BRCA mutation in young, single women of childbearing age.
    Hamilton R; Hurley KE
    Oncol Nurs Forum; 2010 Sep; 37(5):627-34. PubMed ID: 20797954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically at-risk status and individual agency. A qualitative study on asymptomatic women living with genetic risk of breast/ovarian cancer.
    Caiata-Zufferey M
    Soc Sci Med; 2015 May; 132():141-8. PubMed ID: 25813728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
    Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
    Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Cancer doesn't have an age': genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24.
    Werner-Lin A; Hoskins LM; Doyle MH; Greene MH
    Health (London); 2012 Nov; 16(6):636-54. PubMed ID: 22547552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
    Bluman LG; Rimer BK; Berry DA; Borstelmann N; Iglehart JD; Regan K; Schildkraut J; Winer EP
    J Clin Oncol; 1999 Mar; 17(3):1040-6. PubMed ID: 10071299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.
    Staton AD; Kurian AW; Cobb K; Mills MA; Ford JM
    Fam Cancer; 2008; 7(2):179-86. PubMed ID: 18026853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal cancer risk management trajectories of BRCA1/2 mutation-positive reproductive-age women.
    Young JL; Werner-Lin A; Mueller R; Hoskins L; Epstein N; Greene MH
    J Psychosoc Oncol; 2017; 35(4):393-408. PubMed ID: 28332940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of high-risk women toward preimplantation genetic diagnosis.
    Quinn G; Vadaparampil S; Wilson C; King L; Choi J; Miree C; Friedman S
    Fertil Steril; 2009 Jun; 91(6):2361-8. PubMed ID: 18440521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Being young, female, and BRCA positive.
    Hamilton R
    Am J Nurs; 2012 Oct; 112(10):26-31, quiz 46, 32. PubMed ID: 22982855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
    Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
    Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.
    Quinn GP; Vadaparampil ST; Miree CA; Lee JH; Zhao X; Friedman S; Yi S; Mayer J
    Hum Reprod; 2010 Oct; 25(10):2543-50. PubMed ID: 20713415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
    Menon U; Harper J; Sharma A; Fraser L; Burnell M; ElMasry K; Rodeck C; Jacobs I
    Hum Reprod; 2007 Jun; 22(6):1573-7. PubMed ID: 17428877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.